Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 4/20 | 1.00 |
| ▸ | RCOR1 | Q9UKL0 | 3/20 | 0.89 |
| ▸ | LDHB | P07195 | 4/20 | 0.43 |
| ▸ | TERF2IP | Q9NYB0 | 2/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.36 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.36 |
| ▸ | NPY1R | P25929 | 1/20 | 0.36 |
| ▸ | NPY2R | P49146 | 1/20 | 0.36 |
| ▸ | NPY4R | P50391 | 1/20 | 0.36 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.36 |
| ▸ | TERF2 | Q15554 | 1/20 | 0.35 |
| ▸ | F11 | P03951 | 2/20 | 0.35 |
| ▸ | JAK1 | P23458 | 1/20 | 0.35 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.35 |
| ▸ | STAT1 | P42224 | 1/20 | 0.35 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.35 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31066574 | 1.00 | KDM1A (1.00) | KDM1ARCOR1LDHBTERF2IPESR1 | |
| SCHEMBL18902532 | 1.00 | KDM1A (1.00) | KDM1ARCOR1LDHBTERF2IPESR1 | |
| SCHEMBL21476977 | 1.00 | KDM1A (1.00) | KDM1ARCOR1LDHBTERF2IPESR1 | |
| SCHEMBL29394303 | 0.99 | KDM1A (0.99) | KDM1ARCOR1LDHBTERF2IPESR1 | |
| SCHEMBL25641510 | 0.99 | KDM1A (0.99) | KDM1ARCOR1LDHBTERF2IPESR1 | |
| SCHEMBL21474097 | 0.99 | KDM1A (0.99) | KDM1ARCOR1LDHBTERF2IPESR1 | |
| SCHEMBL14845813 | 0.99 | KDM1A (0.99) | KDM1ARCOR1LDHBTERF2IPESR1 | |
| SCHEMBL21474060 | 0.98 | KDM1A (0.96) | KDM1ARCOR1LDHBTERF2IPESR1 | |
| SCHEMBL24437319 | 0.98 | KDM1A (0.96) | KDM1ARCOR1LDHBTERF2IPESR1 | |
| SCHEMBL691747 | 0.98 | KDM1A (0.96) | KDM1ARCOR1LDHBTERF2IPESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 34280 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4749288-A1 | COMPOSITIONS FOR DETECTING, CHARACTERIZING, AND REMOVING A BIOFILM | COSA Group GmbH (DE) | 2026-05-27 | — | — | EP | claimed |
| EP-4747263-A1 | LIPID NANOPARTICLES AND USES THEREOF | University of Connecticut (US) | 2026-05-27 | — | — | EP | claimed |
| CN-122081106-A | Probiotic and application of vesicles thereof in preventing or treating inflammatory bowel disease | — | 2026-05-26 | — | — | CN | claimed |
| CN-120068265-B | Protective shell rib layout and forming method and device thereof | HUNAN UNIVERSITY (CN) | 2026-05-26 | — | — | CN | claimed |
| US-20260138957-A1 | UREA-LINKED 2-AMINOIMIDAZOLE DIMER POTENTIATORS | UNIVERSITY OF NOTRE DAME DU LAC (US) | 2026-05-21 | — | — | US | claimed |
| WO-2026106551-A1 | ANTIMICROBIAL PEPTIDE NANONETS AND METHODS OF USE THEREOF | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2026-05-21 | — | — | WO | claimed |
| EP-4743153-A1 | MEDICAL SYSTEMS FOR TREATING CONDITIONS AND DISEASES OF THE PATIENT'S BODY CAVITIES | UTT Urine Topical Treatment Ltd (IL) | 2026-05-20 | — | — | EP | claimed |
| EP-4132929-B1 | NOVEL NATURE-INSPIRED ANTICANCER AND ANTIBACTERIAL MOTIFS AND PHARMACEUTICAL COMPOSITION THEREOF | UNIV OF SHARJAH (AE) | 2026-05-20 | — | — | EP | claimed |
| EP-4041275-B1 | TREATMENT AND PREVENTION OF NEPHROTOXIN-INDUCED KIDNEY INJURIES | FARSIGHT MEDICAL TECH SHANGHAI CO LTD (CN) | 2026-05-20 | — | — | EP | claimed |
| CN-115215923-B | Macrocyclic broad-spectrum antibiotics | 豪夫迈·罗氏有限公司 | 2026-05-19 | — | — | CN | claimed |
| US-4409209-A | POTENTIATION OF ANTIBIOTICS | CIBA-GEIGY CORPORATION (US) | 1983-10-11 | — | — | US | claimed |
| EP-0056560-A1 | Active antibiotic compositions, process for their manufacture and process for the antibiotic activity of antibiotics | CIBA-GEIGY AG (CH) | 1982-07-28 | — | — | EP | claimed |
| US-4293539-A | Controlled release formulations and method of treatment | ELI LILLY AND COMPANY (US) | 1981-10-06 | — | — | US | claimed |
| US-4288543-A | SAMPLING IN LIQUID PHASE WITH ANTIGROWTH AGENTS-BIOLOGICAL | PFIZER INC. (US) | 1981-09-08 | — | — | US | claimed |
| US-4268505-A | Pharmaceutical composition comprising a nitrogen-containing polysaccharide and an antibiotic agent, and a method of treating an infectious disease therewith | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1981-05-19 | — | — | US | claimed |
| EP-0025698-A2 | Controlled release formulations | ELI LILLY AND COMPANY (US) | 1981-03-25 | — | — | EP | claimed |
| US-4250267-A | Immobilized biological material | W. R. GRACE & CO. (US) | 1981-02-10 | — | — | US | claimed |
| US-4237229-A | CONTACTING A PROTEIN, ENZYME, COENZYME, OR ANTIBIOTIC WITH AN ISOCYANATE-CAPPED POLYETHERURETHANE COPOLYMER, SHAPING, AND CURING | W. R. GRACE & CO. (US) | 1980-12-02 | — | — | US | claimed |
| US-4122158-A | FOR TREATMENT OF BURNS; BIODEGRADABLE HYDROPHOBIC POLYMER; SUSTAINED RELEASE | ALZA CORPORATION (US) | 1978-10-24 | — | — | US | claimed |
| US-3983209-A | HYDROPHOBIC BIOERODIBLE POLYMER, MICROBIOCIDE OR PROTEOLYTIC ENZYME | ALZA CORPORATION (US) | 1976-09-28 | — | — | US | claimed |